Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsSpecialized PeptidesNasalSubcutaneous

Oxytocin

Also known as: OXT, Pitocin (pharmaceutical brand)

A naturally occurring neuropeptide hormone involved in social bonding, trust, and stress reduction. Used intranasally for social and emotional effects, and medically for labor induction.

Research Status

Clinical Trials

Extensive Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Enhances social bonding and trust
Reduces anxiety and stress response
Improves emotional recognition and empathy
Supports pair-bonding and attachment
May reduce cortisol levels
Enhances prosocial behavior

Side Effects

Nasal irritation or congestion
CommonMild

Occurs with intranasal administration. Usually resolves within minutes to hours. Alternate nostrils with each dose if using intranasal route.

Headache
UncommonMild

May occur shortly after administration. Typically mild and self-resolving. Ensure adequate hydration.

Facial flushing or warmth
UncommonMild

Transient vasodilation effect. Usually lasts 5-15 minutes. No intervention required.

Nausea
UncommonMild

More common at higher doses. May be reduced by taking with food or reducing dose.

Mild anxiety or emotional sensitivity
UncommonMild

Paradoxical response in some individuals, particularly those with social anxiety or trauma history. Consider dose reduction or discontinuation if persistent.

Injection site reactions (subcutaneous)
UncommonMild

Localized redness, itching, or mild pain at injection site. Rotate sites to minimize. Usually resolves within hours.

Hyponatremia (low sodium)
RareSerious

Oxytocin has mild antidiuretic properties. Risk increases with high doses or prolonged use. Symptoms include confusion, headache, seizures. Seek medical attention if suspected. Monitor sodium levels with chronic use.

Uterine contractions (in women)
RareModerate

Oxytocin stimulates uterine smooth muscle. Women of childbearing age should be aware of potential menstrual changes or cramping. Avoid use during pregnancy.

Changes in blood pressure
RareModerate

Oxytocin can cause transient changes in blood pressure. Individuals with hypertension or cardiovascular disease should use with caution and medical supervision.

Dosing Reference

ParameterValue
Dose range10-40 IU
Frequency1-2x daily
TimingBefore social situations or as needed for intranasal; varies for medical IV use
RouteNasal, Subcutaneous

Intranasal dosing for behavioral/emotional effects. IV administration reserved for medical use (labor induction, postpartum hemorrhage). Research dosing typically 10-40 IU intranasally. For research purposes only.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight1007.19
Half-life1-6 minutes (IV); 10-20 minutes (intranasal, due to slower absorption)
SequenceCYIQNCPLG

Oxytocin is a neuropeptide hormone that binds to oxytocin receptors in the brain, particularly in regions associated with social behavior, emotional processing, and stress regulation (amygdala, anterior cingulate cortex, and nucleus accumbens). It modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol release and promoting parasympathetic nervous system activity. This leads to increased trust, empathy, and social bonding while simultaneously reducing anxiety and defensive responses.

Oxytocin Receptor Signaling

Oxytocin binds to G-protein coupled oxytocin receptors (OXTR) throughout the brain and peripheral tissues, activating intracellular signaling cascades that modulate neural activity in social and emotional processing centers.

HPA Axis Modulation

Oxytocin inhibits corticotropin-releasing hormone (CRH) and suppresses ACTH and cortisol release, reducing the physiological stress response and promoting relaxation.

Amygdala Regulation

Oxytocin reduces amygdala reactivity to threatening stimuli, decreasing fear and anxiety responses while enhancing social approach behaviors.

Dopamine and Reward Pathways

Oxytocin enhances dopamine signaling in the nucleus accumbens and ventral tegmental area, reinforcing social bonding and prosocial behaviors.

  • Oxytocin is a 9-amino acid cyclic peptide synthesized in the hypothalamus and released by the posterior pituitary
  • Intranasal oxytocin bypasses the blood-brain barrier more effectively than systemic administration
  • Oxytocin effects are context-dependent and modulated by individual differences in receptor density and genetic polymorphisms
  • The peptide has both central (brain) and peripheral (systemic) effects on social behavior, stress, and reproduction

Track your Oxytocin research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Oxytocin is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.